These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8683101

  • 21. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
    Green KA, Noelle RJ, Green WR.
    Virology; 1998 Feb 15; 241(2):260-8. PubMed ID: 9499800
    [Abstract] [Full Text] [Related]

  • 22. Disordered lymphoid purine metabolism contributes to the pathogenesis of persistent Borrelia garinii infection in mice.
    Yegutkin GG, Hytönen J, Samburski SS, Yrjänäinen H, Jalkanen S, Viljanen MK.
    J Immunol; 2010 May 01; 184(9):5112-20. PubMed ID: 20357256
    [Abstract] [Full Text] [Related]

  • 23. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
    Thomsen AR, Nansen A, Christensen JP, Andreasen SO, Marker O.
    J Immunol; 1998 Nov 01; 161(9):4583-90. PubMed ID: 9794385
    [Abstract] [Full Text] [Related]

  • 24. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
    Borges L, Miller RE, Jones J, Ariail K, Whitmore J, Fanslow W, Lynch DH.
    J Immunol; 1999 Aug 01; 163(3):1289-97. PubMed ID: 10415026
    [Abstract] [Full Text] [Related]

  • 25. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.
    Nakajima A, Kodama T, Morimoto S, Azuma M, Takeda K, Oshima H, Yoshino S, Yagita H, Okumura K.
    J Immunol; 1998 Aug 15; 161(4):1901-7. PubMed ID: 9712059
    [Abstract] [Full Text] [Related]

  • 26. Development of lyme arthritis in mice deficient in inducible nitric oxide synthase.
    Brown CR, Reiner SL.
    J Infect Dis; 1999 Jun 15; 179(6):1573-6. PubMed ID: 10228086
    [Abstract] [Full Text] [Related]

  • 27. Impaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice.
    Wang G, Ma Y, Buyuk A, McClain S, Weis JJ, Schwartz I.
    FEMS Microbiol Lett; 2004 Feb 16; 231(2):219-25. PubMed ID: 14987768
    [Abstract] [Full Text] [Related]

  • 28. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis.
    Anguita J, Rincón M, Samanta S, Barthold SW, Flavell RA, Fikrig E.
    J Infect Dis; 1998 Nov 16; 178(5):1512-5. PubMed ID: 9780277
    [Abstract] [Full Text] [Related]

  • 29. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination.
    Linehan LA, Warren WD, Thompson PA, Grusby MJ, Berton MT.
    J Immunol; 1998 Jul 01; 161(1):302-10. PubMed ID: 9647237
    [Abstract] [Full Text] [Related]

  • 30. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154.
    Mackey MF, Gunn JR, Ting PP, Kikutani H, Dranoff G, Noelle RJ, Barth RJ.
    Cancer Res; 1997 Jul 01; 57(13):2569-74. PubMed ID: 9205055
    [Abstract] [Full Text] [Related]

  • 31. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival.
    Yin D, Zhang L, Wang R, Radvanyi L, Haudenschild C, Fang Q, Kehry MR, Shi Y.
    J Immunol; 1999 Oct 15; 163(8):4328-34. PubMed ID: 10510372
    [Abstract] [Full Text] [Related]

  • 32. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.
    Schaible UE, Gay S, Museteanu C, Kramer MD, Zimmer G, Eichmann K, Museteanu U, Simon MM.
    Am J Pathol; 1990 Oct 15; 137(4):811-20. PubMed ID: 2221014
    [Abstract] [Full Text] [Related]

  • 33. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses.
    Lazarus JJ, Meadows MJ, Lintner RE, Wooten RM.
    J Immunol; 2006 Nov 15; 177(10):7076-85. PubMed ID: 17082624
    [Abstract] [Full Text] [Related]

  • 34. Immunology of Lyme disease.
    Sigal LH.
    N J Med; 1990 Jul 15; 87(7):567-71. PubMed ID: 2200983
    [Abstract] [Full Text] [Related]

  • 35. Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement.
    Bockenstedt LK, Barthold S, Deponte K, Marcantonio N, Kantor FS.
    Infect Immun; 1993 May 15; 61(5):2104-7. PubMed ID: 8478100
    [Abstract] [Full Text] [Related]

  • 36. The effect of UV irradiation on infection of mice with Borrelia burgdorferi.
    Brown EL, Ullrich SE, Pride M, Kripke ML.
    Photochem Photobiol; 2001 May 15; 73(5):537-44. PubMed ID: 11367577
    [Abstract] [Full Text] [Related]

  • 37. Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein.
    Feng S, Hodzic E, Barthold SW.
    Infect Immun; 2000 Jul 15; 68(7):4169-73. PubMed ID: 10858233
    [Abstract] [Full Text] [Related]

  • 38. CD4+ T helper 1 cells facilitate regression of murine Lyme carditis.
    Bockenstedt LK, Kang I, Chang C, Persing D, Hayday A, Barthold SW.
    Infect Immun; 2001 Sep 15; 69(9):5264-9. PubMed ID: 11500394
    [Abstract] [Full Text] [Related]

  • 39. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity.
    Fikrig E, Barthold SW, Sun W, Feng W, Telford SR, Flavell RA.
    Immunity; 1997 May 15; 6(5):531-9. PubMed ID: 9175831
    [Abstract] [Full Text] [Related]

  • 40. Immunologic aspects of Lyme borreliosis.
    Dattwyler RJ, Volkman DJ, Luft BJ.
    Rev Infect Dis; 1989 May 15; 11 Suppl 6():S1494-8. PubMed ID: 2682961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.